Urinary Transferrin and Emerging Biomarkers for Early Detection of Diabetic Kidney Disease

Authors

  • Alyaa Hefny Adel Mohey ElDeen , Ibrahim Mohamed Salem , Hanan Samir Ahmed , Fatma M. Attia Elsayed , Alsayed Alnahal Author

DOI:

https://doi.org/10.48047/gdsjck95

Keywords:

diabetic kidney disease, urinary transferrin, early detection, novel biomarkers

Abstract

Background: Diabetic kidney disease (DKD) can develop through glomerular, tubular, inflammatory, and fibrotic pathways, while 
albuminuria and estimated glomerular filtration rate may fail to reveal some early pathological changes. Urinary transferrin has emerged as a candidate marker of abnormal glomerular protein permeability and tubular protein handling

Downloads

Download data is not yet available.

References

American Diabetes Association Professional Practice Committee for Diabetes. (2026). 11. Chronic kidney disease and risk management: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement 1), S246–S260.

Gembillo, G., Soraci, L., Messina, R., Lo Cicero, L., et al. (2026). Urinary biomarkers of diabetic kidney disease. World Journal of Diabetes, 17(1), 110502.

Downloads

Published

2024-11-20

Issue

Vol. 53 No. 03 (2024): Year 2024, Volume 53, Issue 3

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Urinary Transferrin and Emerging Biomarkers for Early Detection of Diabetic Kidney Disease (Alyaa Hefny Adel Mohey ElDeen , Ibrahim Mohamed Salem , Hanan Samir Ahmed , Fatma M. Attia Elsayed , Alsayed Alnahal , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 8727-8736. https://doi.org/10.48047/gdsjck95